The cytoplasmic location of chicken mx is not the determining factor for its lack of antiviral activity.
BACKGROUND
Chicken Mx belongs to the Mx family of interferon-induced dynamin-like GTPases, which in some species possess potent antiviral properties. Conflicting data exist for the antiviral capability of chicken Mx. Reports of anti-influenza activity of alleles encoding an Asn631 polymorphism have not been supported by subsequent studies. The normal cytoplasmic localisation of chicken Mx may influence its antiviral capacity. Here we report further studies to determine the antiviral potential of chicken Mx against Newcastle disease virus (NDV), an economically important cytoplasmic RNA virus of chickens, and Thogoto virus, an orthomyxovirus known to be exquisitely sensitive to the cytoplasmic MxA protein from humans. We also report the consequences of re-locating chicken Mx to the nucleus.


RESULTS
Chicken Mx was tested in virus infection assays using NDV. Neither the Asn631 nor Ser631 Mx alleles (when transfected into 293T cells) showed inhibition of virus-directed gene expression when the cells were subsequently infected with NDV. Human MxA however did show significant inhibition of NDV-directed gene expression. Chicken Mx failed to inhibit a Thogoto virus (THOV) minireplicon system in which the cytoplasmic human MxA protein showed potent and specific inhibition. Relocalisation of chicken Mx to the nucleus was achieved by inserting the Simian Virus 40 large T antigen nuclear localisation sequence (SV40 NLS) at the N-terminus of chicken Mx. Nuclear re-localised chicken Mx did not inhibit influenza (A/PR/8/34) gene expression during virus infection in cell culture or influenza polymerase activity in A/PR/8/34 or A/Turkey/50-92/91 minireplicon systems.


CONCLUSIONS
The chicken Mx protein (Asn631) lacks inhibitory effects against THOV and NDV, and is unable to suppress influenza replication when artificially re-localised to the cell nucleus. Thus, the natural cytoplasmic localisation of the chicken Mx protein does not account for its lack of antiviral activity.
Benfield
Camilla T O
CT
Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom. c.benfield@imperial.ac.uk
Lyall
Jon W
JW
Tiley
Laurence S
LS
D000483:Alleles; D000818:Animals; D000998:Antiviral Agents / Q000378:metabolism* / Q000494:pharmacology*; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D002645:Chickens; D003593:Cytoplasm / Q000378:metabolism*; D019204:GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects / Q000502:physiology; D051379:Mice; D064547:Myxovirus Resistance Proteins; D009522:Newcastle disease virus / Q000187:drug effects; D011110:Polymorphism, Genetic / Q000235:genetics; D021381:Protein Transport; D018117:Thogotovirus / Q000187:drug effects; D018116:Vesiculovirus / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; C579071:MX1 protein, human; C579070:Mx1 protein, mouse; D064547:Myxovirus Resistance Proteins; D019204:GTP-Binding Proteins
Microbiol Immunol. 2002;46(1):29-36
11911186
J Biol Chem. 2009 May 29;284(22):15206-14
19297326
J Virol. 2001 Oct;75(19):9282-6
11533190
Virology. 1985 Jan 15;140(1):192-6
3880978
Biochem Biophys Res Commun. 2004 Oct 15;323(2):541-6
15369785
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6806-11
17426143
J Virol. 2003 Jan;77(2):1501-11
12502864
J Virol. 1997 Apr;71(4):2591-9
9060610
J Virol. 1994 Nov;68(11):6910-7
7933071
J Gen Virol. 2007 Apr;88(Pt 4):1319-1323
17374778
Cell. 1984 Dec;39(3 Pt 2):499-509
6096007
J Virol. 1993 Aug;67(8):4760-8
8392613
J Virol. 1992 Apr;66(4):2564-9
1548781
EMBO J. 1992 Apr;11(4):1657-61
1314172
J Interferon Cytokine Res. 1995 Jan;15(1):47-53
7648434
Cell. 1990 Jul 13;62(1):51-61
2194673
Gene. 1988 Jun 15;66(1):1-10
3417148
J Virol. 1990 Dec;64(12):6263-9
2173790
J Virol. 1995 Jul;69(7):4506-10
7769712
J Gen Virol. 2004 Dec;85(Pt 12):3689-3698
15557242
Gene. 1991 Dec 15;108(2):193-9
1660837
Avian Dis. 2007 Mar;51(1 Suppl):393-5
17494592
Am J Vet Res. 2007 Sep;68(9):988-94
17764414
Proc Soc Exp Biol Med. 1964 Jun;116:506-9
14193387
J Virol. 1993 Mar;67(3):1653-7
8382314
Mol Cell Biol. 1985 Aug;5(8):2150-3
3939324
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8957-62
15184662
J Virol. 2007 Oct;81(19):10818-21
17652381
Genome Res. 2002 Apr;12(4):595-601
11932243
Virology. 1977 Nov;83(1):150-62
18625483
J Biol Chem. 2005 May 13;280(19):19393-400
15757897
Virology. 1993 Jul;195(1):100-12
8100373
J Virol. 2008 Apr;82(7):3624-31
18199636
Proc Natl Acad Sci U S A. 1983 Apr;80(7):1910-4
6188159
J Virol. 1995 Jun;69(6):3904-9
7745744
J Interferon Cytokine Res. 2007 Oct;27(10):847-55
17970694
Virology. 1996 Jun 15;220(2):330-8
8661384
Traffic. 2004 Dec;5(12):979-92
15522099
Cell. 1986 Jan 17;44(1):147-58
3000619
Virology. 2008 Oct 10;380(1):152-6
18723201
J Virol Methods. 2003 Mar;108(1):19-28
12565150
J Virol. 2003 Aug;77(16):8676-85
12885886
Virology. 2007 Jun 20;363(1):166-73
17307214
J Interferon Cytokine Res. 2006 Sep;26(9):650-60
16978069
J Virol. 2000 Jan;74(1):560-3
10590150
J Virol. 1993 Nov;67(11):6726-32
8411374
J Virol. 2008 Aug;82(15):7533-9
18508886
J Virol. 1985 Oct;56(1):201-6
2411949
J Virol. 2001 May;75(10):4823-31
11312354
Rev Sci Tech. 2009 Apr;28(1):219-31
19618628
Immunogenetics. 2008 Nov;60(11):689-97
18726592
FEBS Lett. 1999 Dec 10;463(1-2):24-8
10601631
Anim Genet. 2004 Apr;35(2):119-22
15025571
Nucleic Acids Res. 2004 Jan 29;32(2):643-52
14752052
J Virol. 1990 Jul;64(7):3370-5
2161946
Virology. 1962 Feb;16:203-4
14465449